With multi-resistant germs becoming more and more of a threat, we are in need of new antibiotics now more than ever. Unfortunately, antibiotics cannot distinguish between pathogens and beneficial microbes. They can destroy the delicate balance of the microbiome – resulting in permanent damages. The research team around chemist Dr Thomas Böttcher has now made a significant step towards solving these problems. In collaboration with the team around biologist Professor Christof Hauck, also from Konstanz, the researchers discovered antibiotic properties of a natural product that so far had been considered merely a bacterial signal molecule. The team, including the doctoral researchers Dávid Szamosvári and Tamara Schuhmacher, developed and investigated synthetic derivatives of the natural substance that proved surprisingly efficient against the pathogen Moraxella catarrhalis. In the process only the growth of these pathogens was inhibited, not the growth of other bacteria. In a further project, the researchers succeed in developing another selective agent to combat the malaria parasite. These results might lead to a new basis for novel precision antibiotics. The research results are published in the current editions of the journals Chemical Science and Chemical Communications.
As important as antibiotics are to treat infectious diseases, they leave a trail of destruction in the human microbiome. Gastrointestinal disorders following antibiotic treatments are one of the slightest problems in this context. Quite often, resistant pathogens replace beneficial microbes. Later on, these can cause severe infectious diseases or chronic illnesses. However, not all microbes are dangerous. On the contrary, many microorganisms live in peaceful coexistence with us, and are even vital for human health. We humans are true microcosms and host more microbes than human cells. Yet this ecosystem, the human microbiome, is fragile. Allergies, overweight, chronic inflammatory bowel diseases and even psychiatric disorders may be the result of a damaged microbiome. The question is how can we maintain this ecological diversity in case of a microbial infection?
The research team originally studied the signals of the bacterium Pseudomonas aeruginosa. A compound aroused their interest as it was highly selectively inhibiting the growth of the pathogen Moraxella catarrhalis. This pathogen causes, for example, otitis media in children as well as infections in patients with chronically obstructive pulmonary diseases. The synthetic scaffold engineering of this natural product resulted in a new compound class with enormous antibiotic efficiency. What was really surprising was the substance’s selectivity: Only the growth of Moraxella catarrhalis was inhibited, not that of other bacteria. Even closely related bacteria from the same species remained completely unaffected.
Currently, Thomas Böttcher and Christof Hauck are investigating the mechanism of action of this highly selective antibiotic against the pathogen Moraxella catarrhalis. Antibiotics with such selectivity would make precision treatment possible and specifically eliminate pathogens while preserving the diversity of beneficial microbes.
Learn more: Selective antibiotics following nature’s example
The Latest on: Precision antibiotics
via Google News
The Latest on: Precision antibiotics
- OHSU study advances field of precision medicineon February 27, 2021 at 6:12 am
The discovery, published in the journal Nature Communications, builds upon previous advances by OHSU scientists in single-cell genome sequencing. The study represents another milestone in the field of ...
- QF and Al Jazeera make documentary on precision medicineon February 26, 2021 at 11:34 pm
Qatar Foundation (QF) has teamed up with Al Jazeera to produce a documentary on precision medicine which was aired on Thursday on Al Jazeera Arabic.
- A Decade of Thyroid Cancer Research Brings Precision Medicine to the Forefront of Careon February 26, 2021 at 12:51 pm
The rising prevalence of thyroid cancer and thyroid nodules, especially for differentiated thyroid cancer, has brought into question the management of disease as it is known today.
- OHSU study represents a new milestone in the field of precision medicineon February 26, 2021 at 8:59 am
The study represents another milestone in the field of precision medicine. It gives us a lot more precision. The single-cell aspect gives us the ability to track the molecular changes within each cell ...
- Study advances field of precision medicineon February 26, 2021 at 8:02 am
Researchers at Oregon Health & Science University have demonstrated a new method of quickly mapping the genome of single cells, while also clarifying the spatial position of the cells within the body.
- New approach can help treat hypertrophic cardiomyopathy with precision medicineon February 25, 2021 at 10:32 pm
Hypertrophic cardiomyopathy (HCM) is a cardiovascular disease characterized by thickening of the left ventricle, otherwise known as the main squeezing chamber of the heart. HCM is best known for ...
- Precision Medicine Market Research Report, Size, Share, Trends, Growth, Top Key Players, Applications, Types, Product and Industry Analysis 2027on February 24, 2021 at 7:33 pm
The global Precision Medicine Market is expected to reach USD 132.66 Billion by 2027, according to a new report ...
- New Study Will Aim to Advance Precision Medicine for Lung Canceron February 24, 2021 at 10:25 am
The five-year study will aim to accelerate precision medicine options for patients with non-small cell lung cancer.
- Rare versus common diseases: a false dichotomy in precision medicineon February 24, 2021 at 4:07 am
Precision medicine initiatives are being launched worldwide, each with the capacity to sequence many thousands to millions of human genomes. At the strategic planning level, all are debating the ...
- Precision Medicine Market 2021 Global Share, Trend, Segmentation, Analysis and Forecast to 2026on February 23, 2021 at 12:54 pm
Precision Medicine Market 2021 Global Precision Medicine Market Analysis Summary The global market has explained that all ...
via Bing News